[account_shop_links]
Brazil: Clinical Development Country Profile
$2,960.00 – $5,920.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
In this report, ISR provides insight into the clinical trial regulation and development environment, sponsor and service provider activities, and population “health status” for Brazil.
What you will learn:
- How population health status, regulations and clinical trial activity, and international and domestic company partnerships make Brazil one of the top emerging global pharmaceutical markets
- Insights from domestic service provider organizations on conducting clinical trials
- in Brazil
- Clinical trial operational metrics for Brazil-only clinical studies
- Compiled lists and contact details for domestic and international service providers in Brazil
How you can use this report:
- Understand how Brazil compares to other countries on a variety of health condition scales so the reader can best consider the areas in which Brazil may be beneficial as a trail site
- Understand the legal, logistical, and regulatory details for conducting Brazilian trials, and illustrate the benefits and drawbacks of conducting trials in Brazil
Methodology:
ISR gathered content for this report via an exhaustive secondary research effort and from company profile questionnaires that were distributed to CROs profiled in this report.
